19 /100
LOW RISK
Score updated May 30, 2026

PTPI — Petros Pharmaceuticals, Inc. Dilution Risk Tracker

Track PTPI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track PTPI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.01 below $1 exchange minimum
🔔 Track PTPI — Get forecast alerts →

💹 Market Data

Market Cap$258.5K
Shares Outstanding42.37M
Float36.25M
Cash$4.35M
Debt$1.74M
Short InterestN/A

🏛 Institutional Holdings

10.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track PTPI for full holder detail →

📉 Short Interest

Short Interest754
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track PTPI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking PTPI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: A AAON ABLZF ACIW ADT
🔬 More Research for PTPI
📊 PTPI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 PTPI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.